Elizabeth Arden, Inc. Announces Third Quarter Fiscal 2013 Results

  Elizabeth Arden, Inc. Announces Third Quarter Fiscal 2013 Results

              ~ Net Sales of $264.5 Million; Increase of 10.5% ~

                          ~ Adjusted EPS of $0.02 ~

~ Fiscal Year-to-Date Net Sales Increase of 11%; Adjusted EPS Increase of 14%
                                      ~

Business Wire

NEW YORK -- May 02, 2013

Elizabeth Arden, Inc. (NASDAQ: RDEN), a global prestige beauty products
company, today announced financial results for its third fiscal quarter ended
March 31, 2013.

THIRD QUARTER RESULTS

For the quarter ended March 31, 2013, the Company reported net sales of $264.5
million, an increase of 10.5% as compared to the third quarter of the prior
fiscal year. Excluding the unfavorable impact of foreign currency translation,
net sales increased by 11.2%.

On a reported basis, net loss per diluted share for the quarter ended March
31, 2013 was $0.04. On an adjusted basis, net income per diluted share for the
current year period was $0.02, as compared to net income per diluted share of
$0.07 for the prior year period. The adjusted net income per diluted share for
the current fiscal quarter was impacted by $0.03 per share as a result of a
year-to-date revision of the expected adjusted tax rate to 25%. As such, the
adjusted net income per share is based on an effective tax rate of 63.6% for
the quarter ended March 31, 2013. This compares to an effective tax rate of
5.6% for the prior year period. Adjusted net income per diluted share excludes
acquisition-related expenses and non-recurring charges associated with the
Elizabeth Arden brand repositioning. A reconciliation between GAAP and
adjusted results can be found in the tables and footnotes at the end of this
press release.

In North America, net sales increased 9.4% for the quarter and 12.2% fiscal
year-to-date. Sales growth was driven by new launches, including Pink Friday
Nicki Minaj, Justin Bieber's Girlfriend and Taylor Swift Wonderstruck
Enchanted, and growth in existing fragrance brands, including the Juicy
Couture fragrances.

Internationally, net sales grew 14% (at constant rates) for the third fiscal
quarter and 11.1% (at constant rates) fiscal year-to-date. Net sales of
fragrances in the international segment have increased 22% (at constant rates)
for the third fiscal quarter and 16% (at constant rates) for the first nine
months of fiscal 2013, behind the Company's Western European fragrance
initiative. Fragrance sales in Europe grew 33% (at constant rates) for the
quarter and 22% (at constant rates) fiscal year-to-date.

Net sales of Elizabeth Arden branded products increased by approximately 1%
(at constant rates) for the quarter and fiscal year-to-date on a global basis.
Retail sales at the Company's Elizabeth Arden flagship counters have increased
22% in North America year over year since conversion, and retail sales at the
Company’s international flagship doors have increased 18% in the aggregate
since conversion. These increases are driven by the retail sales performance
of skin care and color.

E. Scott Beattie, Chairman, President and Chief Executive Officer of Elizabeth
Arden, Inc., commented, "We continue to execute against our key growth
initiatives. Sales of fragrances expanded strongly in all of our key fragrance
markets this quarter. During the quarter, we opened our affiliate in Brazil
and began commercial sales in that market in February. We also continue to be
very excited with the traction we are seeing with the Elizabeth Arden brand
repositioning and the momentum of retail sales increases in our Elizabeth
Arden flagship doors. As we mentioned, the flagship model was established as a
way for us to test, learn, and gather feedback on the repositioning of the
Elizabeth Arden brand, as well as to build confidence in the growth potential
of the brand with our key retail partners. Our focus is on extending key
elements of the flagship model to drive the Elizabeth Arden brand on a global
basis."

NINE MONTH RESULTS

For the nine months ended March 31, 2013, the Company reported net sales of
$1,076.9 million, an increase of 10.7%, as compared to the prior year period.
Excluding the unfavorable impact of foreign currency translation, net sales
increased by 11.8%. On a reported basis, net income per diluted share for the
nine months ended March 31, 2013 was $1.50. On an adjusted basis, net income
per diluted share was $2.04, as compared to net income per diluted share of
$1.79 for the prior year period. Adjusted net income per diluted share
excludes acquisition-related expenses and non-recurring charges associated
with the Elizabeth Arden brand repositioning. A reconciliation between GAAP
and adjusted results can be found in the tables and footnotes at the end of
this press release.

OUTLOOK

The Company is confirming its latest revenue and earnings guidance for fiscal
2013. For the full fiscal year ending June 30, 2013, the Company expects net
sales to increase by 9% to 11%, assuming an expected unfavorable impact from
foreign currency of approximately 0.6%, as compared to the prior year period,
and for adjusted earnings per diluted share to be in the range of $2.30 to
$2.50.

The earnings guidance excludes non-recurring charges related to the Elizabeth
Arden brand repositioning and expenses related to the acquisitions completed
in the fourth quarter of fiscal 2012. The Company has incurred a total of
$24.4 million of acquisition-related and non-recurring Elizabeth Arden brand
repositioning expenses in the nine months ended March 31, 2013. The remainder
of the Elizabeth Arden brand repositioning charges, currently estimated at
$1.5 million (pre-tax), is expected to be incurred in the fourth quarter of
fiscal 2013. No additional acquisition-related expenses are expected to be
incurred in fiscal 2013.

The Company will introduce fiscal 2014 guidance in August 2013 when it reports
its fourth quarter and fiscal 2013 financial results.

The guidance is based on current foreign currency rates. The Company also
notes that continued global economic uncertainty may have a negative effect on
retailer and consumer confidence and demand, and, along with the foreign
currency volatility, makes forecasting difficult.

CONFERENCE CALL INFORMATION

The Company will host a conference call today at 11:00 a.m. Eastern Time. All
interested parties can listen to a live web cast of the Company's conference
call by visiting the Investor Relations section of the Corporate tab on the
Company's web site at http://ir.elizabetharden.com. An online archive of the
broadcast will be available within one hour of the completion of the call and
will be accessible on the Company's web site until June 4, 2013.

Elizabeth Arden is a global prestige beauty products company with an extensive
portfolio of prestige beauty brands sold in over 120 countries. The company's
brand portfolio includes Elizabeth Arden skincare, color and fragrance
products, the celebrity fragrance brands of Britney Spears, Elizabeth Taylor,
Justin Bieber, Mariah Carey, Nicki Minaj, Taylor Swift, and Usher; the
designer fragrance brands of Juicy Couture, Alfred Sung, BCBGMAXAZRIA,
Geoffrey Beene, Halston, Ed Hardy, John Varvatos, Kate Spade, Lucky Brand,
True Religion and Rocawear; and the lifestyle fragrance brands Curve, Giorgio
Beverly Hills, and PS Fine Cologne.

                                                
                                                   
ELIZABETH ARDEN, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF OPERATIONS DATA
(Unaudited)
(In thousands, except percentages and per share data)
                                                   
                       Three Months Ended          Nine Months Ended
                       March 31,    March 31,     March 31,      March 31,
                       2013          2012          2013            2012
                                                                   
Net Sales              $ 264,484     $ 239,279     $ 1,076,944     $ 972,739
Cost of Goods Sold:
Cost of Sales            136,643       118,781       562,220         489,548
Depreciation Related
to Cost of Goods        1,656       906         4,674         3,850   
Sold
Total Cost of Goods      138,299       119,687       566,894         493,398
Sold
                                                                   
Gross Profit             126,185       119,592       510,050         479,341
Gross Profit             47.7    %     50.0    %     47.4      %     49.3    %
Percentage
                                                                   
Selling, General and
Administrative           111,597       104,582       404,257         371,480
Expenses
Depreciation and        10,254      7,645       28,755        21,433  
Amortization
Total Operating          121,851       112,227       433,012         392,913
Expenses
Interest Expense,        5,893         5,291         18,515          16,339
Net
(Loss) Income Before     (1,559  )     2,074         58,523          70,089
Income Taxes
(Benefit from)
Provision for Income    (286    )    (117    )    12,803        16,295  
Taxes
                                                                   
Net (Loss) Income      $ (1,273  )   $ 2,191      $ 45,720       $ 53,794  
                                                                   
Net (Loss) Income      $ (0.04   )   $ 0.08        $ 1.54          $ 1.85
Per Basic Share
Net (Loss) Income      $ (0.04   )   $ 0.07        $ 1.50          $ 1.79
Per Diluted Share
                                                                   
Basic Shares             29,607        29,116        29,658          29,017
Diluted Shares           29,607        30,069        30,498          29,997
                                                                   
EBITDA (a)             $ 16,244      $ 15,916      $ 110,467       $ 111,711
EBITDA margin (a)        6.1     %     6.7     %     10.3      %     11.5    %
                                                                   
Adjusted to exclude
acquisition-related
and Elizabeth Arden
repositioning
costs, net of taxes
(b)(c):
                                                                   
Gross Profit           $ 129,561     $ 119,592     $ 533,578       $ 479,341
Gross Profit             49.0    %     50.0    %     49.5      %     49.3    %
Percentage
                                                                   
Net Income             $ 716         $ 2,191       $ 62,214        $ 53,794
                                                                   
Net Income Per Basic   $ 0.02        $ 0.08        $ 2.10          $ 1.85
Share
Net Income Per         $ 0.02        $ 0.07        $ 2.04          $ 1.79
Diluted Share
                                                                   
EBITDA (a)             $ 19,768      $ 15,916      $ 134,869       $ 111,711
EBITDA margin (a)        7.5     %     6.7     %     12.5      %     11.5    %

(a) EBITDA is defined as net income plus the provision for income taxes (or
net loss less the benefit from income taxes) plus interest expense, plus
depreciation and amortization. EBITDA should not be considered as an
alternative to income (loss) from operations or net income (loss) (as
determined in accordance with generally accepted accounting principles (GAAP))
as a measure of our operating performance or to net cash provided by
operating, investing and financing activities (as determined in accordance
with GAAP) or as a measure of our ability to meet cash needs. We believe that
EBITDA is a measure commonly reported and widely used by investors and other
interested parties as a measure of a company's operating performance and debt
servicing ability because it assists in comparing performance on a consistent
basis without regard to capital structure, depreciation and amortization or
non-operating factors (such as historical cost). Accordingly, as a result of
our capital structure, we believe EBITDA is a relevant measure. This
information has been disclosed here to permit a more complete comparative
analysis of our operating performance relative to other companies and of our
debt servicing ability. EBITDA may not, however, be comparable in all
instances to other similar types of measures. We have also disclosed EBITDA as
adjusted without giving effect to acquisition-related and Elizabeth Arden
repositioning costs. This disclosure is being provided for comparability
purposes because we believe it is meaningful to our investors and other
interested parties to understand the EBITDA performance of the Company on a
consistent basis without regard to the effect of acquisition-related and
Elizabeth Arden repositioning costs.

The table below reconciles net (loss) income, as determined in accordance with
GAAP, to EBITDA and to EBITDA as adjusted: (For a reconciliation of net income
to EBITDA for prior periods, see the Company's filings with the Securities and
Exchange Commission which can be found on the Company's website at
www.elizabetharden.com.)

(Amounts in thousands)        Three Months Ended       Nine Months Ended
                               March 31,   March 31,    March 31,  March 31,
                               2013         2012         2013        2012
                                                                     
Net (loss) income              $ (1,273 )   $ 2,191      $ 45,720    $ 53,794
Plus:
(Benefit from) Provision for     (286   )     (117   )     12,803      16,295
income taxes
Interest expense, net            5,893        5,291        18,515      16,339
Depreciation related to cost     1,656        906          4,674       3,850
of goods sold
Depreciation and                10,254     7,645      28,755     21,433
amortization
EBITDA                           16,244       15,916       110,467     111,711
Acquisition-related and
Elizabeth Arden                 3,524      --         24,402     --
repositioning costs (c)
EBITDA, as adjusted            $ 19,768    $ 15,916    $ 134,869   $ 111,711

The table below reconciles net cash flow (used in) provided by operating
activities, as determined in accordance with GAAP, to EBITDA:

(Amounts in thousands)                            Nine Months Ended
                                                     March 31,    March 31,
                                                     2013          2012
Net cash (used in) provided by operating             $ (8,848  )   $ 50,331
activities
Changes in assets and liabilities, net of              99,639        45,318
acquisitions
Interest expense, net                                  18,515        16,339
Amortization of senior note offering and               (1,024  )     (931    )
credit facility costs
Provision for income taxes                             12,803        16,295
Deferred income taxes                                  (6,371  )     (11,883 )
Amortization of share-based awards                    (4,247  )    (3,758  )
EBITDA                                               $ 110,467    $ 111,711 

(b) The table below reconciles the calculation of (i) net (loss) income and
(ii) net (loss) income per share on a basic and diluted basis from the amounts
reported in accordance with GAAP to such amounts before giving effect to
acquisition-related and Elizabeth Arden repositioning costs. This disclosure
is being provided for comparability purposes because we believe it is
meaningful to our investors and other interested parties to understand the
Company's operating performance on a consistent basis without regard to the
effect of acquisition-related and Elizabeth Arden repositioning costs. The
presentation in the table below of the non-GAAP information titled "Net income
as adjusted" and "Net income per basic and diluted share as adjusted" is not
meant to be considered in isolation or as a substitute for net (loss) income
or net (loss) income per basic and diluted share prepared in accordance with
GAAP.

(In thousands,
except per share       Three Months Ended         Nine Months Ended
data)
                         March 31,    March 31,     March 31,    March 31,
                         2013          2012          2013          2012
Gross Profit:
Gross Profit as          $ 126,185     $ 119,592    $ 510,050    $ 479,341 
reported
Acquisition-related
and Elizabeth Arden       3,376       --          23,528      --      
repositioning costs
(c)
Gross Profit as          $ 129,561    $ 119,592    $ 533,578    $ 479,341 
adjusted
                                                                   
Net Income:
Net (loss) income as     $ (1,273  )   $ 2,191       $ 45,720      $ 53,794
reported
Acquisition-related
and Elizabeth Arden       1,989       --          16,494      --      
repositioning costs
(c)
Net income as            $ 716        $ 2,191      $ 62,214     $ 53,794  
adjusted
                                                                   
Net Income Per Basic
Share:
Net (loss) income
per basic share as       $ (0.04   )   $ 0.08        $ 1.54        $ 1.85
reported
Acquisition-related
and Elizabeth Arden       0.06        --          0.56        --      
repositioning costs,
net of tax (c) (d)
Net income per basic     $ 0.02       $ 0.08       $ 2.10       $ 1.85    
share as adjusted
                                                                   
Net Income Per
Diluted Share:
Net (loss) income
per diluted share as     $ (0.04   )   $ 0.07        $ 1.50        $ 1.79
reported
Acquisition-related
and Elizabeth Arden       0.06        --          0.54        --      
repositioning costs,
net of tax (c) (d)
Net income per
diluted share as         $ 0.02       $ 0.07       $ 2.04       $ 1.79    
adjusted

(c) For the three months ended March 31, 2013, gross profit includes $0.6
million (pre-tax) of inventory–related costs primarily for inventory purchased
by us from New Wave Fragrances LLC and Give Back Brands LLC prior to the
acquisition of licenses and certain other assets from those companies and
other transition costs, and $2.8 million (pre-tax) of non-recurring product
changeover costs related to the repositioning of the Elizabeth Arden brand. In
addition, income from operations includes $0.1 million (pre-tax) in transition
costs associated with the 2012 acquisitions and $0.1 million (pre-tax) of
non-recurring product changeover expenses, related to the repositioning of the
Elizabeth Arden brand that were recorded in selling, general and
administrative expenses. For the nine months ended March 31, 2013, gross
profit and net income include $13.8 million (pre-tax) of inventory–related
costs ($6.4 million of which did not require the use of cash in the current
period) primarily for inventory purchased by us from New Wave Fragrances LLC
and Give Back Brands LLC prior to the fragrance license acquisitions from
those companies and $9.7 million (pre-tax) of costs related to the
repositioning of the Elizabeth Arden brand. In addition, net income includes
$0.4 million (pre-tax) in transition costs associated with the New Wave
Fragrances LLC and Give Back Brands LLC acquisitions and $0.5 million
(pre-tax) of expenses related to the repositioning of the Elizabeth Arden
brand that were recorded in selling, general and administrative expenses.

(d) Our effective tax rate on a reported basis, which is calculated as a
percentage of (loss) income before income taxes, was 18.3% and 21.9% for the
three and nine months ended March 31, 2013, respectively. On a reported basis,
for the three and nine months ended March 31, 2012, our effective tax rate was
5.6% and 23.2%, respectively. On an adjusted basis, our effective tax rate was
63.6%.and 25.0% for the three and nine months ended March 31, 2013,
respectively.


SEGMENT NET SALES

The table below is a comparative summary of our net sales by reportable segment for the three and nine
months ended March 31, 2013 and 2012:

(In            Three Months Ended     % Increase         Nine Months Ended        % Increase
thousands)                              (Decrease)                                    (Decrease)
                March 31,   March 31,            Constant   March 31,     March 31,            Constant
                2013       2012        GAAP    Rates      2013         2012        GAAP    Rates
                                                 (e)                                           (e)
Segment Net                                                                               
Sales
North America   $ 158,746   $ 145,154   9.4  %   9.5   %    $ 701,380     $ 625,215   12.2 %   12.2  %
International    105,738   94,125    12.3 %  14.0  %     375,564     347,524   8.1  %  11.1  %
Total           $ 264,484   $ 239,279   10.5 %   11.3  %    $ 1,076,944   $ 972,739   10.7 %   11.8  %

                                                                               
PRODUCT CATEGORY NET SALES

The table below is a comparative summary of our net sales by product category for the three and nine
months ended March 31, 2013 and 2012:
                                                                                    
(In           Three Months Ended      % Increase          Nine Months Ended         % Increase
thousands)                            (Decrease)                                    (Decrease)
              March 31,   March 31,            Constant   March 31,     March 31,             Constant
              2013       2012        GAAP    Rates      2013         2012        GAAP     Rates
                                               (e)                                            (e)
Product
Category                                                                                 
Net Sales:
Elizabeth
Arden         $ 106,239   $ 106,082   0.1  %   0.7   %    $ 362,675     $ 363,948   (0.3 )%   1.4   %
Brand
Celebrity,
Lifestyle,
Designer      158,245   133,197   18.8 %  19.7  %     714,269     608,791   17.3 %   18.1  %
and
Other
Fragrances
Total         $ 264,484   $ 239,279   10.5 %   11.3  %    $ 1,076,944   $ 972,739   10.7 %    11.8  %

(e) Constant currency information compares results between periods assuming
exchange rates had remained constant period-over-period and excludes gains and
losses from foreign currency contracts in all periods. We calculate constant
currency information by translating current-period results using prior-year
GAAP foreign currency exchange rates. The gains and/or losses from foreign
currency contracts were not material for all periods presented.

                                                                
ELIZABETH ARDEN, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEET DATA
(Unaudited)
                                                                     
(In thousands)                           March 31,     June 30,      March 31,
                                         2013          2012          2012
Cash                                     $ 31,442      $ 59,080      $ 58,207
Accounts Receivable, Net                   230,757       188,141       172,852
Inventories                                326,430       291,987       272,532
Property and Equipment, Net                96,166        89,438        80,703
Exclusive Brand Licenses, Trademarks
and                                        301,061       314,502       221,738
Intangibles, Net
Goodwill                                   21,054        21,054        21,054
Total Assets                               1,104,335     1,066,754     910,237
Short-Term Debt                            116,250       89,200        --
Current Liabilities                        283,311       278,679       160,746
Long-Term Liabilities                      295,612       306,348       267,386
Long-Term Debt                             250,000       250,000       250,000
Shareholders' Equity                       525,412       481,727       482,105
Working Capital                            379,450       345,818       410,295

                                                 
SUPPLEMENTARY CASH FLOW INFORMATION
(Unaudited)
(In thousands)
                                                     
                                                     Nine Months Ended
                                                     March 31,    March 31,
                                                     2013          2012
                                                                   
Net cash (used in) provided by operating             $ (8,848  )   $ 50,331
activities
Net cash used in investing activities                  (38,456 )     (60,685 )
Net cash provided by financing activities              20,410        10,919
Net (decrease) increase in cash and cash               (27,638 )     (643    )
equivalents

In connection with the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995, Elizabeth Arden, Inc. is hereby providing
cautionary statements identifying important factors that could cause our
actual results to differ materially from those projected in forward-looking
statements (as defined in such act). Any statements that are not historical
facts and that express, or involve discussions as to, expectations, beliefs,
plans, objectives, assumptions or future events or performance (often, but not
always, indicated through the use of words or phrases such as "will likely
result," "are expected to," "will continue," "is anticipated," "should,"
"estimated," "intends," "plans," "believes" and "projects") may be
forward-looking and may involve estimates and uncertainties which could cause
actual results to differ materially from those expressed in the
forward-looking statements. These statements include, but are not limited to,
our guidance and expectations regarding net sales, earnings, gross margins,
operating cash flow and returns on invested capital. In addition, any such
statements are qualified in their entirety by reference to, and are
accompanied by, the following key factors that have a direct bearing on our
results of operations:

  *factors affecting our relationships with our customers or our customers'
    businesses, including the absence of contracts with customers, our
    customers' financial condition, and changes in the retail, fragrance and
    cosmetic industries, such as the consolidation of retailers and the
    associated closing of retail doors as well as retailer inventory control
    practices, including, but not limited to, levels of inventory carried at
    point of sale and practices used to control inventory shrinkage;
  *risks of international operations, including foreign currency
    fluctuations, hedging activities, economic and political consequences of
    terrorist attacks, disruptions in travel, unfavorable changes in U.S. or
    international laws or regulations, diseases and pandemics, and political
    instability in certain regions of the world;
  *our reliance on license agreements with third parties for the rights to
    sell many of our prestige fragrance brands;
  *our reliance on third-party manufacturers for substantially all of our
    owned and licensed products and our absence of contracts with suppliers of
    distributed brands and components for manufacturing of owned and licensed
    brands;
  *delays in shipments, inventory shortages and higher supply chain costs due
    to the loss of or disruption in our distribution facilities or at key
    third party manufacturing or fulfillment facilities that manufacture or
    provide logistic services for our products;
  *our ability to respond in a timely manner to changing consumer preferences
    and purchasing patterns and other international and domestic conditions
    and events that impact retailer and/or consumer confidence and demand,
    such as domestic or global recessions or economic uncertainty;
  *our ability to protect our intellectual property rights;
  *the success, or changes in the timing or scope, of our new product
    launches, advertising and merchandising programs;
  *the quality, safety and efficacy of our products;
  *the impact of competitive products and pricing;
  *our ability to (i) implement our growth strategy and acquire or license
    additional brands or secure additional distribution arrangements, (ii)
    successfully and cost-effectively integrate acquired businesses or new
    brands, and (iii) finance our growth strategy and our working capital
    requirements;
  *our level of indebtedness, our ability to realize sufficient cash flows
    from operations to meet our debt service obligations and working capital
    requirements, and restrictive covenants in our revolving credit facility,
    second lien facility and the indenture for our 7 3/8% senior notes;
  *changes in product mix to less profitable products;
  *the retention and availability of key personnel;
  *changes in the legal, regulatory and political environment that impact, or
    will impact, our business, including changes to customs or trade
    regulations, laws or regulations relating to ingredients or other
    chemicals or raw materials contained in products or packaging, or
    accounting standards or critical accounting estimates;
  *the success of our global Elizabeth Arden brand repositioning efforts;
  *the impact of tax audits, including the ultimate outcome of the pending
    Internal Revenue Service examination of our U.S. federal tax returns for
    the fiscal years ended June 30, 2008 and June 30, 2009, changes in tax
    laws or tax rates, and our ability to utilize our deferred tax assets;
  *our ability to effectively implement, manage and maintain our global
    information systems and maintain the security of our confidential data and
    our employees' and customers' personal information;
  *our reliance on third parties for certain outsourced business services,
    including information technology operations, logistics management and
    employee benefit plan administration;
  *the potential for significant impairment charges relating to our
    trademarks, goodwill or other intangible assets that could result from a
    number of factors, including downward pressure on our stock price; and
  *other unanticipated risks and uncertainties.

We caution that the factors described herein could cause actual results to
differ materially from those expressed in any forward-looking statements we
make and that investors should not place undue reliance on any such
forward-looking statements. Further, any forward-looking statement speaks only
as of the date on which such statement is made, and we undertake no obligation
to update any forward-looking statement to reflect events or circumstances
after the date on which such statement is made or to reflect the occurrence of
anticipated or unanticipated events or circumstances. New factors emerge from
time to time, and it is not possible for us to predict all of such factors.
Further, we cannot assess the impact of each such factor on our results of
operations or the extent to which any factor, or combination of factors, may
cause actual results to differ materially from those contained in any
forward-looking statements. This press release is qualified in its entirety by
the cautionary statements and risk factor disclosure contained in our
Securities and Exchange Commission filings, including our Annual Report on
Form 10-K for the year ended June 30, 2012.

Contact:

Company Contact:
Elizabeth Arden, Inc.
Marcey Becker, Senior Vice President, Finance
or
Investor/Press Contact:
Integrated Corporate Relations
Allison Malkin/Michael Fox, 203-682-8200
 
Press spacebar to pause and continue. Press esc to stop.